Abstract
The Korean Journal of Urology (KJU) has taken a great leap towards becoming a highly regarded international journal. This July, KJU was selected to be indexed in MEDLINE, a bibliographic database of the U.S. National Library of Medicine (NLM). MEDLINE includes citations from over 5,600 scholarly journals published around the world. Currently, KJU is among 18 journals in Korea that are indexed. The National Institutes of Health-chartered advisory committee, the Literature Selection Technical Review Committee (LSTRC), reviews and recommends journals for MEDLINE. The LSTRC considers the quality of the scientific content of a journal, including originality and the importance of the content for the MEDLINE global audience. A distinctive feature of MEDLINE is that it uses the NLM controlled vocabulary, Medical Subject Headings (MeSH), to index citations. The KJU has been indexed in PubMed and PubMed Central since 2010 [1]. With the January issue of 2010, KJU took a giant leap towards its quest to becoming an international journal. At that time, the official language of the journal changed from Korean to English, which was a historical event in the life of the Korean Urological Association [2]. After the journal was indexed in PubMed and PubMed Central, the journal’s impact factor from the Web of Science and its impact index from SCImago Journal began to increase dramatically [3]. Likewise, being indexed in an internationally well-known journal database such as MEDLINE will provide easy access to the KJU for many international readers and researchers. MEDLINE is an internationally respected premier database in the field of biomedicine. Therefore, the indexing of the KJU by MEDLINE is an outstanding achievement and another giant leap on the journal’s path to becoming a renowned international journal. This achievement will broaden the range of international readers and will increase the number of submissions of high-quality articles. It will also provide a strong driving force for our editorial team in their efforts to build a high-quality international
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
